文献速递骨质疏松与钙磷/甲状旁腺甲状腺疾病

成骨细胞和破骨细胞祖细胞中甲状腺激素转运体Mct8缺失增加雄性小鼠的骨小梁

Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice.
PubMed 文献 · Thyroid · 2020-01-31

研究使用12周龄雄性小鼠的全身性或条件性Mct8敲除模型,发现全身性敲除导致血清T3升高1.7倍、骨小梁骨量减少28%,但条件性敲除成骨祖细胞或破骨祖细胞中的Mct8分别使骨小梁骨量增加16%和20%。研究证实全身性敲除中高T3掩盖了Mct8对骨的直接作用,Mct8通过调节T3摄取调控骨小梁与皮质骨。

要点

  • 全身性Mct8敲除雄性小鼠血清T3升高1.7倍,骨小梁骨量减少28%。
  • 成骨祖细胞特异性Mct8敲除使骨小梁骨量增加16%,成骨细胞数增加3.7倍。
  • 破骨祖细胞Mct8缺失使骨小梁骨量增加20%,破骨细胞数减少32%。

核心结论

  • 全身性Mct8敲除小鼠的高循环T3掩盖了Mct8缺失对骨的直接效应。
  • Mct8通过调节T3摄取调控骨小梁与皮质骨,并在成骨细胞和破骨细胞祖细胞中发挥细胞内在作用。

研究设计与样本

  • 研究分析12周龄雄性小鼠,包括全身性Mct8敲除以及靶向破骨祖细胞、成骨祖细胞、成熟成骨细胞和骨细胞的条件性Mct8敲除品系,评估骨微结构、骨转换和骨强度,并进行体外实验研究Mct8在骨细胞分化和功能及T3摄取中的作用。

主要发现

  • 全身性Mct8敲除小鼠血清T3浓度升高1.7倍,骨小梁骨量减少28%,成骨细胞数增加45%,破骨细胞数增加41%,皮质骨矿物质密度增加。
  • 体外培养显示Mct8在成熟骨细胞中表达最高,Mct8缺失导致成骨细胞和破骨细胞分化标志物mRNA表达降低、矿化能力下降及破骨细胞数减少。
  • 成骨祖细胞特异性Mct8敲除使骨小梁骨量增加16%,成骨细胞数增加3.7倍;成骨祖细胞和晚期成骨细胞/骨细胞中Mct8缺失均导致皮质骨丢失。
  • 破骨祖细胞Mct8缺失使骨小梁骨量增加20%,破骨细胞数减少32%,成骨细胞数增加25%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Bone is an important target of thyroid hormones (THs), which require transport into target cells to exert their actions. Recently, the TH-specific monocarboxylate transporter 8 (Mct8) was reported as a regulator of bone mass in male mice. However, its global deletion leads to high 3,3',5-L-triiodothyronine (T3) serum concentrations that may mask direct effects of Mct8-deficiency on bone. In this study, we assessed the bone cell intrinsic function of Mct8 ex vivo and in vivo using conditional Mct8-knockout lines specifically targeting osteoclast and osteoblast progenitors, as well as mature osteoblasts and osteocytes. Materials and Methods: Twelve-week-old male mice with a global Mct8-deficiency or a conditional Mct8-knockout in osteoclast precursors, osteoprogenitors, or mature osteoblasts/osteocytes were analyzed regarding their bone microarchitecture, turnover, and strength. Furthermore, ex vivo studies were conducted to investigate the role of Mct8 in bone cell differentiation and functionality, as well as TH uptake. Results: Global Mct8-knockout mice demonstrated 1.7-fold higher T3 serum concentrations and trabecular bone loss (-28%) likely due to an increased bone turnover as shown by increased osteoblast (+45%) and osteoclast numbers (+41%). However, cortical bone mineral density was increased. Ex vivo cultures of bone marrow-derived osteoblasts and osteoclasts revealed highest expression of Mct8 in mature bone cells. In addition, Mct8-deficiency resulted in a lower mRNA expression of osteoblast and osteoclast differentiation markers, as well as a reduced mineralization capacity and osteoclast numbers, respectively, indicating a bone cell intrinsic role of Mct8. In fact, conditional Mct8-knockout and inhibition of Mct8 in osteoblasts led to an attenuated T3 uptake ex vivo. In vivo, osteoprogenitor-specific Mct8-knockout enhanced trabecular bone volume (+16%) with osteoblast numbers being increased 3.7 fold. Interestingly, Mct8-deficiency in osteoprogenitors and late osteoblasts/osteocytes both resulted in cortical bone loss. Finally, Mct8-deletion in osteoclast progenitors increased trabecular bone volume (+20%) due to reduced osteoclast numbers (-32%), whereas osteoblast numbers were enhanced (+25%). Conclusions: This study confirms that high systemic T3 in global Mct8-knockout mice masks the direct effect of Mct8. Moreover, it identifies Mct8 as a critical regulator of trabecular vs. cortical bone by regulating T3 uptake and highlights its cell intrinsic role in osteoclast and osteoblast progenitors.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Lademann F, Tsourdi E, Rijntjes E, et al. Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice. Thyroid. 2020. PMID: 31910109. doi:10.1089/thy.2019.0271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。